These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 26383769)
1. Polio elimination in Nigeria: A review. Nasir UN; Bandyopadhyay AS; Montagnani F; Akite JE; Mungu EB; Uche IV; Ismaila AM Hum Vaccin Immunother; 2016 Mar; 12(3):658-63. PubMed ID: 26383769 [TBL] [Abstract][Full Text] [Related]
2. Progress toward poliomyelitis eradication in Nigeria. Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862 [TBL] [Abstract][Full Text] [Related]
3. Understanding vaccine hesitancy in polio eradication in northern Nigeria. Taylor S; Khan M; Muhammad A; Akpala O; van Strien M; Morry C; Feek W; Ogden E Vaccine; 2017 Nov; 35(47):6438-6443. PubMed ID: 29031691 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria. Michael CA; Ashenafi S; Ogbuanu IU; Ohuabunwo C; Sule A; Corkum M; Mackay S; Storms AD; Achari P; Biya O; Nguku P; Newberry D; Bwaka A; Mahoney F; J Infect Dis; 2014 Nov; 210 Suppl 1():S131-5. PubMed ID: 25316827 [TBL] [Abstract][Full Text] [Related]
14. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194 [TBL] [Abstract][Full Text] [Related]
15. The global polio eradication initiative: lessons learned and prospects for success. Aylward B; Tangermann R Vaccine; 2011 Dec; 29 Suppl 4():D80-5. PubMed ID: 22486981 [TBL] [Abstract][Full Text] [Related]
16. Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013-2014. Warigon C; Mkanda P; Muhammed A; Etsano A; Korir C; Bawa S; Gali E; Nsubuga P; Erbeto TB; Gerlong G; Banda R; Yehualashet YG; Vaz RG J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S79-85. PubMed ID: 26908717 [TBL] [Abstract][Full Text] [Related]
17. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria. Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155 [TBL] [Abstract][Full Text] [Related]
18. Descriptive epidemiology of poliomyelitis cases due to wild poliovirus type 1 and wild poliovirus type 3 in Nigeria, 2000-2020. Bammeke P; Adamu US; Bolu O; Waziri N; Erberto T; Aregay A; Nsubuga P; Wiesen E; Shuaib F Pan Afr Med J; 2023; 45(Suppl 2):4. PubMed ID: 38370099 [TBL] [Abstract][Full Text] [Related]